HRA® offers compensation of $500 to physicians for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.

Please note: this is a non-CME, unsponsored program. All content is independently developed by the Urology Times® team.

OVERVIEW

Urology Times® Clinical Forum are collaborative, small-group meeting designed around case-based clinical profiles and peer-dialogue led by an expert physician. This session offers practicing urologists the perfect opportunity to sharpen their skills and expertise in treatment strategies. 

LEARNING OBJECTIVES

• Explore the evolving NMIBC treatment landscape, focusing on advances in perioperative strategies, the changing dynamics within the multidisciplinary team (MDT), and how these shifts are influencing current and future treatment approaches. 
• Examine the critical role of the multidisciplinary team (MDT) in advancing bladder cancer care and discuss strategies to enhance coordination across the diagnostic and treatment continuum. 
• Discuss emerging data surrounding ADC-based perioperative strategies in MIBC and examine their implications for future treatment practices and real-world integration in community oncology.